Blog
About

6
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Efficacy and Safety of Edoxaban in Nonvalvular Atrial Fibrillation: A Meta-analysis of Randomized Controlled Trials.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Edoxaban is a potential alternative to warfarin for preventing thromboembolism in atrial fibrillation. However, the efficacy and safety, and the optimal regimen of edoxaban are still controversial. This study compared the efficacy and safety of edoxaban and warfarin in nonvalvular atrial fibrillation, and the effects of different edoxaban dosages.

          Related collections

          Author and article information

          Journal
          J Stroke Cerebrovasc Dis
          Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association
          Elsevier BV
          1532-8511
          1052-3057
          Dec 2015
          : 24
          : 12
          Affiliations
          [1 ] Department of Cardiology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong 510080, China.
          [2 ] Department of Cardiology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong 510080, China. Electronic address: wanglich@mail.sysu.edu.cn.
          Article
          S1052-3057(15)00429-2
          10.1016/j.jstrokecerebrovasdis.2015.07.026
          26324517

          Comments

          Comment on this article